Inhibiting AChE and Butyrylcholinesterase (BChE) has developed into a standard method for treating the symptoms of neurodegenerative diseases like Alzheimer’s disease [99]. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.